Business

LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study

LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study

Lumos Diagnostics Holdings Ltd.August 31, 20253
LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study

About this update from Lumos Diagnostics Holdings Ltd.

Lumos Diagnostics Holdings Ltd has released a press release. View Attachment

View stock analysis, news, and events for Lumos Diagnostics Holdings Ltd.

More from Lumos Diagnostics Holdings Ltd.

All Lumos Diagnostics Holdings Ltd. news →